No Evidence for an Effect of COMT Val158Met Genotype on Executive Function in Patients With 22q11 Deletion Syndrome | Zendy

Bronwyn Glaser | Zendy; Martin Debbané | Zendy; Christine Hinard | Zendy; Michael A. Morris | Zendy; Sophie Dahoun | Zendy; Stylianos E. Antonarakis | Zendy; Stéphan Eliez | Zendy

AI Assistant Blog Pricing

Open Access

No Evidence for an Effect of COMT Val158Met Genotype on Executive Function in Patients With 22q11 Deletion Syndrome

Author(s) -

Bronwyn Glaser,

Martin Debbané,

Christine Hinard,

Michael A. Morris,

Sophie Dahoun,

Stylianos E. Antonarakis,

Stéphan Eliez

Publication year - 2006

Publication title -

american journal of psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.477

H-Index - 353

eISSN - 1535-7228

pISSN - 0002-953X

DOI - 10.1176/appi.ajp.163.3.537

Subject(s) - deletion syndrome , genotype , function (biology) , medicine , psychology , genetics , biology , phenotype , gene

Previous studies linking the catechol O-methyltransferase (COMT) functional polymorphism to the specific phenotype in 22q11.2 deletion syndrome (22q11.2DS) have yielded inconsistent results. The goal of the present study was to replicate a recent finding that executive function is higher in individuals hemizygous for the Met allele.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog